Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Nutex Health (NUTX) EPS (Basic) (2016 - 2026)

Nutex Health (NUTX) has disclosed EPS (Basic) for 17 consecutive years, with $6.7 as the latest value for Q1 2026.

  • For Q1 2026, EPS (Basic) rose 79.14% year-over-year to $6.7; the TTM value through Mar 2026 reached $13.52, down 1.89%, while the annual FY2025 figure was $11.13, 8.8% up from the prior year.
  • EPS (Basic) hit $6.7 in Q1 2026 for Nutex Health, up from $1.5 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $11.83 in Q4 2024 and bottomed at -$7.47 in Q4 2023.
  • Average EPS (Basic) over 5 years is $1.0, with a median of -$0.07 recorded in 2024.
  • Year-over-year, EPS (Basic) plummeted 37250.0% in 2023 and then surged 4775.0% in 2025.
  • Nutex Health's EPS (Basic) stood at -$0.02 in 2022, then tumbled by 37250.0% to -$7.47 in 2023, then skyrocketed by 258.37% to $11.83 in 2024, then plummeted by 87.32% to $1.5 in 2025, then skyrocketed by 346.67% to $6.7 in 2026.
  • According to Business Quant data, EPS (Basic) over the past three periods came in at $6.7, $1.5, and $8.27 for Q1 2026, Q4 2025, and Q3 2025 respectively.